Drug Persistency of Two Cholinesterase Inhibitors: Rivastigmine versus Donepezil in Elderly Patients with Alzheimers Disease

Author： Suh Dong-Churl

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.22, Iss.8, 2005-01, pp. : 695-707

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk of Antipsychotic Drug Use in Patients with Alzheimers Disease Treated with Rivastigmine

By Suh D-C.

Drugs & Aging, Vol. 21, Iss. 6, 2004-01 ,pp. : 395-403

Adis International

Access to resources Recommend Favorite

Inpharma, Vol. 1, Iss. 1507, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 486, 2005-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimers Disease

By Jönsson L.

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1025-1037

Adis International

Access to resources Recommend Favorite

Use of Antipsychotic Drugs in Patients with Alzheimer's Disease Treated with Rivastigmine versus Donepezil: A Retrospective, Parallel-Cohort, Hypothesis-Generating Study

By Scharre Douglas W.

Drugs & Aging, Vol. 27, Iss. 11, 2010-11 ,pp. : 903-913

Adis International

Access to resources Recommend Favorite